healthcare and life sciences industry was the second-largest destination for PE investments in 2013 attracting $1.2 billion across 57 transactions.
Again, the top-three transactions involved secondary purchases from existing investors — the $200-million investment in Gland Pharma (by KKR); the $161-million investment in Naresh Trehan-promoted hospital Medicity (by Carlyle) and the $113-million investment in Emcure Pharmaceuticals (by PE firm Bain Capital).
Manufacturing companies attracted about $1.1 billion from PE investors across 30 transactions. Baring Asia’s R1,400-crore (about $233-million) investment in Lafarge India, the Indian subsidiary of French cement giant Lafarge, was the second-largest transaction. The financial sector received the fourth-largest investments in attracting $727 million across 44 transactions.
Companies based in southern and western regions accounted for 36% of the PE investments each (in value terms) during 2013. While the amount (about $2.7 billion) was spread across 148 investments in south India-based companies, it got spread across 127 transactions among west India-based companies. Companies in north India attracted investments worth $1.8 billion (24% of the value pie) across 84 deals, the report said.